Standard Doses of Cholecalciferol Reduce Glucose and Increase Glutamine in Obesity-Related Hypertension: Results of a Randomized Trial
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(6), P. 3416 - 3416
Published: March 18, 2024
In
arterial
hypertension,
the
dysregulation
of
several
metabolic
pathways
is
closely
associated
with
chronic
immune
imbalance
and
inflammation
progression.
With
time,
these
disturbances
lead
to
development
progressive
disease
end-organ
involvement.
However,
influence
cholecalciferol
on
as
a
possible
mechanism
its
immunomodulatory
activity
in
obesity-related
hypertension
not
known.
phase
2,
randomized,
single-center,
24-week
trial,
we
evaluated,
secondary
outcome,
serum
metabolome
36
age-
gender-matched
adults
vitamin
D
deficiency,
before
after
supplementation
therapy
along
routine
medication.
The
defined
endpoint
was
assessment
circulating
metabolites
using
nuclear
magnetic
resonance-based
metabolomics
approach.
Univariate
multivariate
analyses
were
used
evaluate
systemic
alterations
caused
by
cholecalciferol.
comparison
normotensive
controls,
hypertensive
patients
presented
overall
decreased
expression
amino
acids
(p
<
0.05),
including
ketogenic
glucogenic
properties
well
aromatic
acids.
Following
supplementation,
increases
observed
glutamine
0.001)
histidine
levels
other
remaining
unaffected.
Glucose
0.05)
acetate
24
weeks
group
taking
supplement,
changes
saturation
fatty
also
observed,
suggesting
role
liposoluble
lipid
metabolism.
Long-term
chronically
obese
overweight
hypertensives
induced
blood
metabolome,
which
reflected
metabolism
may
have
fostered
new
microenvironment
for
cell
proliferation
biology.
Of
note,
increased
availability
be
relevant
different
T-cell
subsets.
Language: Английский
The effect of intestinal flora metabolites on macrophage polarization
Hengzhong Lun,
No information about this author
Peilong Li,
No information about this author
Juan Li
No information about this author
et al.
Heliyon,
Journal Year:
2024,
Volume and Issue:
10(15), P. e35755 - e35755
Published: Aug. 1, 2024
Intestinal
flora
metabolites
played
a
crucial
role
in
immunomodulation
by
influencing
host
immune
responses
through
various
pathways.
Macrophages,
as
type
of
innate
cell,
were
essential
chemotaxis,
phagocytosis,
inflammatory
responses,
and
microbial
elimination.
Different
macrophage
phenotypes
had
distinct
biological
functions,
regulated
diverse
factors
mechanisms.
Advances
intestinal
sequencing
metabolomics
have
enhanced
understanding
how
affect
functions.
These
varying
effects
on
polarization
different
mechanisms
influence.
This
study
summarized
the
impact
gut
microbiota
phenotype
function,
along
with
underlying
associated
produced
flora.
Language: Английский
Hsa_Circ_0008035 drives immune evasion of gastric cancer via promoting EXT1-mediated nuclear translocation of PKM2
Rongqi Jiang,
No information about this author
Ping Li,
No information about this author
Enqing Meng
No information about this author
et al.
Translational Oncology,
Journal Year:
2024,
Volume and Issue:
48, P. 102004 - 102004
Published: July 24, 2024
Circular
RNAs
(circRNAs)
have
been
reported
to
be
associated
with
the
malignant
phenotypes
of
cancer.
However,
role
and
underlying
mechanism
hsa_Circ_0008035
in
colorectal
cancer
(CRC)
remains
unclear.
In
this
study,
we
elucidated
pivotal
hsa_circ_0008035
gastric
progression
immune
evasion.
Elevated
levels
patient
serum
correlated
positively
disease
advancement,
including
tumor
stages
lymph
node
metastasis.
Functional
analyses
revealed
a
negative
association
between
CD8+
T
cell
number
function.
Mechanistically,
encoded
novel
protein
EXT1-219aa,
suppressing
EXT1
phosphorylation
expression.
Additionally,
regulated
pyruvate
metabolism
by
influencing
nucleus
localization
PKM2.
The
identified
EXT1/PKM2
axis
further
underscored
intricate
regulatory
mechanisms
orchestrated
cancer,
offering
potential
diagnostic
therapeutic
implications
ongoing
pursuit
targeted
therapies
for
patients.
Language: Английский